To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Bayer HealthCare Licenses Genomatix’ Microarray Analysis Platform ChipInspector
Genomatix has announced that Bayer HealthCare licensed Genomatix microarray analysis platform ChipInspector.
ChipInspector is designed to enable biologists and bio-informaticians to analyze chip raw data from Affymetrix GeneChip and Exon Arrays.
It employs a proprietary single probe approach based on latest genomic annotation from Genomatix' ElDorado annotation pipeline.
Starting with ChipInspector the Genomatix Microarray Analysis Pipeline integrates literature and pathway mining as well as promoter analysis on sequence level in one coherent system.
"After several successful pilot studies we are now very pleased that Bayer HealthCare licensed ChipInspector," states Dr. Martin Seifert, VP Microarray business and collaborative research.
"We expect that ChipInspector will enhance the Affymetrix analysis pipeline starting from GeneChip and Exon Arrays at Bayer."
